TP53 and colorectal cancer: Similarly, the well‐studied combination of APC‐M + KRAS‐M + TP53‐M in colorectal cancers (Fearon & Vogelstein, 1990; Cho & Vogelstein, 1992; Smith et al,2002) was identified as a con‐GCR in READ (conf.: 79) and as a non‐consensus GCR in COAD (conf.: 42).